AROS has a context-dependent effect on SIRT1

Tarja Kokkola1, Tiina Suuronen1, Ferdinand Molnár1

  • 1School of Pharmacy, University of Eastern Finland, Kuopio, Finland.

FEBS Letters
|April 1, 2014
PubMed

Insights

Active regulator of SIRT1 (AROS) does not activate SIRT1 in non-cancerous cells. Instead, AROS inhibits SIRT1 activity in vitro, revealing context-dependent interactions crucial for aging-associated disease research.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Aging Research

Background:

  • Sirtuin 1 (SIRT1) is a key protein deacetylase implicated in aging and age-related diseases.
  • Active regulator of SIRT1 (AROS) was previously suggested to activate SIRT1, particularly in cancer cells.

Purpose of the Study:

  • To investigate the interaction between AROS and SIRT1 in non-cancerous human cells.
  • To determine the effect of AROS on SIRT1 activity in different experimental contexts.

Main Methods:

  • Co-immunoprecipitation assays to assess protein-protein interactions.
  • In vitro SIRT1 activity assays to measure enzyme function.
  • Experiments conducted in non-cancerous human cell lines.

Main Results:

  • The interaction between AROS and SIRT1 in non-cancerous cells was found to be weak.
  • AROS did not alter SIRT1 activity in non-cancerous human cells.
  • In vitro assays demonstrated that AROS acts as an inhibitor of SIRT1.

Conclusions:

  • The functional relationship between AROS and SIRT1 is not a simple activation.
  • AROS's effect on SIRT1 is context-dependent, varying with cell type and experimental conditions.
  • These findings necessitate a re-evaluation of AROS as a therapeutic modulator for aging-associated diseases.

Related Concept Videos

Riboswitches01:56

Riboswitches

Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
8.0K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.5K
RNA Editing02:23

RNA Editing

RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
8.3K
Translational Regulation01:29

Translational Regulation

Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...
877
tRNA Activation02:26

tRNA Activation

Aminoacyl-tRNA synthetases are present in both eukaryotes and bacteria. Though eukaryotes have 20 different aminoacyl-tRNA synthetases to couple to 20 amino acids, many bacteria do not have genes for all of these aminoacyl-tRNA synthetases. Despite this, they still use all 20 amino acids to synthesize their proteins. For instance, some bacteria do not have the gene encoding the enzyme that couples glutamine with its partner tRNA. In these organisms, one enzyme adds glutamic acid to all of the...
18.0K
tRNA Activation02:26

tRNA Activation

7.5K